Pharmacotherapy for the treatment of acute bipolar II Depression: Current evidence

Journal of Clinical Psychiatry

Volumn 72, Issue 3, 2011, Pages 356-366

  Swartz, Holly A ^a   Thase, Michael E ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; GABAPENTIN; ICOSAPENTAENOIC ACID ETHYL ESTER; INOSITOL; LAMOTRIGINE; LITHIUM; LITHIUM CARBONATE; MODAFINIL; OMEGA 3 FATTY ACID; PAROXETINE; PLACEBO; PRAMIPEXOLE; QUETIAPINE; RISPERIDONE; SERTRALINE; VALPROATE SEMISODIUM; VALPROIC ACID; VENLAFAXINE;

ADD ON THERAPY; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DEPRESSION; BIPOLAR II DISORDER; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG RESPONSE; EVIDENCE BASED MEDICINE; HUMAN; LOW DRUG DOSE; MAJOR DEPRESSION; MEDLINE; MONOTHERAPY; OUTCOME ASSESSMENT; PEER REVIEW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW;

ACUTE DISEASE; ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; BENZHYDRYL COMPOUNDS; BENZOTHIAZOLES; BIPOLAR DISORDER; DIBENZOTHIAZEPINES; HUMANS; LITHIUM COMPOUNDS; TRIAZINES;

EID: 79953059030     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.09r05192gre     Document Type: Article

References (60)

1. Merikangas KR, Akiskal HS, Angst J, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry. 2007;64(5):543-552.doi:10.101/archpsyc.64.5. 543 PubMed (Pubitemid 46718287)
2. Judd LL, Akiskal HS, Schettler PJ, et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry. 2003;60(3):261-269.doi:10.101/archpsyc.60.3.261 PubMed (Pubitemid 36307437)
3. Maina G, Albert U, Bellodi L, et al. Health-related quality of life in euthymic bipolar disorder patients: differences between bipolar I and II subtypes. J Clin Psychiatry. 2007;68(2):207-212.doi:10.408/JCP.v68n0205 PubMed (Pubitemid 46362641)
4. Dunner DL, Gershon ES, Goodwin FK. Heritable factors in the severity of affective illness. Biol Psychiatry. 1976;11(1):31-42. PubMed
5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
6. Mantere O, Suominen K, Valtonen HM, et al. Differences in outcome of DSM-IV bipolar I and II disorders. Bipolar Disord. 2008;10(3):413-425.doi:10.1/ j.139-5618.207.0502.x PubMed (Pubitemid 351517375)
7. Judd LL, Akiskal HS, Schettler PJ, et al. The comparative clinical phenotype and long term longitudinal episode course of bipolar I and II: a clinical spectrum or distinct disorders? J Affect Disord. 2003; 73(1-2):19-32.doi:10.1016/S0165-0327(02)0324-5 PubMed (Pubitemid 36044629)
8. Angst J, Gamma A, Benazzi F, et al. Toward a re-definition of subthreshold bipolarity: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania. J Affect Disord. 2003;73(1-2):133-146. doi:10.1016/S0165-0327(02)032-1 PubMed (Pubitemid 36044641)
9. Coryell W, Keller M, Endicott J, et al. Bipolar II illness: course and outcome over a five-year period. Psychol Med. 1989;19(1):129-141.doi:10.1017/ S03291701090 PubMed (Pubitemid 19100273)
10. Coryell W, Endicott J, Winokur G, et al. Characteristics and significance of untreated major depressive disorder. Am J Psychiatry. 1995;152(8): 1124-1129. PubMed
11. Coryell W, Andreasen NC, Endicott J, et al. The significance of past mania or hypomania in the course and outcome of major depression. Am J Psychiatry. 1987;144(3):309-315. PubMed
12. Coryell W. Bipolar II disorder: a progress report. J Affect Disord. 1996; 41(3):159-162.doi:10.1016/S0165-0327(96)086-9 PubMed (Pubitemid 26422945)
13. McMahon FJ, Simpson SG, McInnis MG, et al. Linkage of bipolar disorder to chromosome 18q and the validity of bipolar II disorder. Arch Gen Psychiatry. 2001;58(11):1025-1031.doi:10.101/archpsyc.58.1.1025 PubMed (Pubitemid 33051827)
14. Nwulia EA, Miao K, Zandi PP, et al. Genome-wide scan of bipolar II disorder. Bipolar Disord. 2007;9(6):580-588.doi:10.1/j.139-5618.207.0437.x PubMed (Pubitemid 47365625)
15. Hauser P, Matochik J, Altshuler LL, et al. MRI-based measurements of temporal lobe and ventricular structures in patients with bipolar I and bipolar II disorders. J Affect Disord. 2000;60(1):25-32.doi:10.1016/S0165-0327(9)0154-8 PubMed (Pubitemid 30625241)
16. Benazzi F. Bipolar disorder - focus on bipolar II disorder and mixed depression. Lancet. 2007;369(9565):935-945.doi:10.1016/S0140-6736(07)60453-X PubMed (Pubitemid 46400860)
17. Kupka RW, Altshuler LL, Nolen WA, et al. Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder. Bipolar Disord. 2007;9(5):531-535.doi:10.1/j.139-5618.207.0467.x PubMed (Pubitemid 47202517)
18. Goodwin GM, Anderson I, Arango C, et al. ECNP consensus meeting: bipolar depression. Nice, March 2007. Eur Neuropsychopharmacol. 2008;18(7):535-549.doi: 10.1016/j.euroneuro.208.03.03 PubMed
19. Yatham LN, Kennedy SH, O'Donovan C, et al; Canadian Network for Mood and Anxiety Treatments. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disord. 2005;7(suppl 3):5-69. PubMed
20. International Consensus Group. International Consensus Group on the evidence-based pharmacologic treatment of bipolar I and II depression. J Clin Psychiatry. 2008;69(10):1632-1646.doi:10.408/JCP.v69n1014 PubMed
21. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry. 2002; 159(suppl 4):1-50. PubMed
22. Goodwin GM; Consensus Group of the British Association for Psychopharmacology. Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2003;17(2):149-173. doi:10.17/026981030170203 PubMed
23. Grunze H, Kasper S, Goodwin G, et al; World Federation of Societies of Biological Psychiatry Task Force on Treatment Guidelines for Bipolar Disorders. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders, part I: treatment of bipolar depression. World J Biol Psychiatry. 2002;3(3): 115-124.doi:10.3109/ 1562970209150612 PubMed
24. Calabrese JR, Huffman RF, White RL, et al. Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials. Bipolar Disord. 2008;10(2):323-333.doi:10.1/ j.139-5618.207.050.x PubMed (Pubitemid 351637697)
25. Schaffer A, Zuker P, Levitt A. Randomized, double-blind pilot trial comparing lamotrigine versus citalopram for the treatment of bipolar depression. J Affect Disord. 2006;96(1-2):95-99.doi:10.1016/j.jad.206.05.023 PubMed (Pubitemid 44548053)
26. Suppes T, Hirschfeld RM, Vieta E, et al. Quetiapine for the treatment of bipolar II depression: analysis of data from two randomized, double-blind, placebo-controlled studies. World J Biol Psychiatry. 2008;9(3):198-211. PubMed
27. Amsterdam JD, Wang CH, Shwarz M, et al. Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial. J Affect Disord. 2009;112(1-3):219-230.doi:10.1016/j.jad.208.03.029 PubMed
28. Leverich GS, Altshuler LL, Frye MA, et al. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am J Psychiatry. 2006;163(2):232-239.doi:10.176/api.ajp.163. 2.232 PubMed (Pubitemid 44480842)
29. Ghaemi SN, Gilmer WS, Goldberg JF, et al. Divalproex in the treatment of acute bipolar depression: a preliminary double-blind, randomized, placebo-controlled pilot study. J Clin Psychiatry. 2007;68(12):1840-1844.doi:10. 408/JCP.v68n1203 PubMed
30. Frye MA, Ketter TA, Kimbrell TA, et al. A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol. 2000;20(6):607-614.doi:10.1097/04714-20120-04 PubMed
31. Sachs GS, Nierenberg AA, Calabrese JR, et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med. 2007; 356(17):1711-1722.doi:10.1056/NEJMoa064135 PubMed (Pubitemid 46658703)
32. Young LT, Joffe RT, Robb JC, et al. Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression. Am J Psychiatry. 2000;157(1):124-126. PubMed
33. Parker G, Tully L, Olley A, et al. SSRIs as mood stabilizers for Bipolar II Disorder? a proof of concept study. J Affect Disord. 2006;92(2-3): 205-214.doi:10.1016/j.jad.206.01.024 PubMed
34. Zarate CA Jr, Payne JL, Singh J, et al. Pramipexole for bipolar II depression: a placebo-controlled proof of concept study. Biol Psychiatry. 2004; 56(1):54-60.doi:10.1016/j.biopsych.204.03.013 PubMed (Pubitemid 38813406)
35. Suppes T, Marangell LB, Bernstein IH, et al. A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depression. J Affect Disord. 2008;111(2-3):334-343.doi:10.1016/j.jad.208.02.04 PubMed
36. Frye MA, Grunze H, Suppes T, et al. A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression. Am J Psychiatry. 2007;164(8):1242-1249.doi:10.176/api.ajp.207.06060981 PubMed (Pubitemid 47292414)
37. Nierenberg AA, Ostacher MJ, Calabrese JR, et al. Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. Am J Psychiatry. 2006;163(2):210-216.doi:10.176/api.ajp.163.2.210 PubMed (Pubitemid 44480839)
38. van der Loos ML, Mulder PG, Hartong EG, et al; LamLit Study Group. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial. J Clin Psychiatry. 2009;70(2):223-231.doi:10.408/JCP.08m04152 PubMed
39. Keck PE Jr, Mintz J, McElroy SL, et al. Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder. Biol Psychiatry. 2006;60(9):1020-1022.doi:10.1016/j.biopsych.206.03.056 PubMed (Pubitemid 44739928)
40. Frangou S, Lewis M, McCrone P. Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study. Br J Psychiatry. 2006;188(1):46-50. doi:10.192/bjp.18.1.46 PubMed (Pubitemid 43021926)
41. Calabrese JR, Keck PE Jr, Macfadden W, et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry. 2005;162(7):1351-1360.doi:10.176/api.ajp.162.7.1351 PubMed (Pubitemid 40905587)
42. Thase ME, Macfadden W, Weisler RH, et al; BOLDER II Study Group. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study). J Clin Psychopharmacol. 2006;26(6):600-609.doi:10.1097/01.jcp.0248603.76231.b7 PubMed (Pubitemid 44772737)
43. Calabrese JR, Suppes T, Bowden CL, et al. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder: Lamictal 614 Study Group. J Clin Psychiatry. 2000;61(11): 841-850. PubMed
44. Calabrese JR, Bowden CL, Sachs GS, et al. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression: Lamictal 602 Study Group. J Clin Psychiatry. 1999;60(2): 79-88. PubMed
45. Goodwin GM, Bowden CL, Calabrese JR, et al. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry. 2004;65(3):432-441.doi:10.408/JCP. v65n0321 PubMed
46. Sachs GS, Printz DJ, Kahn DA, et al. The expert consensus guideline series: medication treatment of bipolar disorder. Postgrad Med. 2000;(spec no):1-104. PubMed
47. Geddes JR, Calabrese JR, Goodwin GM. Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry. 2009;194(1):4-9.doi:10.192/ bjp.bp.107.048504 PubMed
48. Lavori PW, Rush AJ, Wisniewski SR, et al. Strengthening clinical effectiveness trials: equipoise-stratified randomization. Biol Psychiatry. 2001; 50(10):792-801.doi:10.1016/S06-323(01)0123-9 PubMed (Pubitemid 33086767)
49. Dunner DL, Stallone F, Fieve RR. Lithium carbonate and affective disorders, part V: a double-blind study of prophylaxis of depression in bipolar illness. Arch Gen Psychiatry. 1976;33(1):117-120. PubMed
50. Fieve RR, Kumbaraci T, Dunner DL. Lithium prophylaxis of depression in bipolar I, bipolar II, and unipolar patients. Am J Psychiatry. 1976;133(8): 925-929. PubMed
51. Kane JM, Quitkin FM, Rifkin A, et al. Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo-controlled comparison. Arch Gen Psychiatry. 1982;39(9):1065-1069. PubMed
52. Tondo L, Baldessarini RJ, Hennen J, et al. Lithium maintenance treatment of depression and mania in bipolar I and bipolar II disorders. Am J Psychiatry. 1998;155(5):638-645. PubMed
53. Vieta E, Martinez-Arán A, Goikolea JM, et al. A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers. J Clin Psychiatry. 2002;63(6):508-512. PubMed
54. Altshuler LL, Suppes T, Black DO, et al. Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants. Am J Psychiatry. 2006;163(2): 313-315.doi:10.176/api.ajp.163.2.313 PubMed (Pubitemid 44480853)
55. Salvi V, Fagiolini A, Swartz HA, et al. The use of antidepressants in bipolar disorder. J Clin Psychiatry. 2008;69(8):1307-1318.doi:10.408/JCP. v69n0816 PubMed
56. Goodwin F, Jamison K. Manic-Depressive Illness. New York, NY: Oxford University Press; 1990.
57. Gijsman HJ, Geddes JR, Rendell JM, et al. Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Am J Psychiatry. 2004;161(9):1537-1547.doi:10.176/api.ajp.161.9.1537 PubMed (Pubitemid 39201448)
58. Amsterdam JD, Garcia-España F, Fawcett J, et al. Efficacy and safety of fluoxetine in treating bipolar II major depressive episode. J Clin Psychopharmacol. 1998;18(6):435-440.doi:10.1097/04714-198120-03 PubMed (Pubitemid 28555325)
59. Amsterdam JD, Garcia-España F. Venlafaxine monotherapy in women with bipolar II and unipolar major depression. J Affect Disord. 2000; 59(3):225-229.doi:10.1016/S0165-0327(9)0149-4 PubMed (Pubitemid 30347545)
60. Parker G. The use of SSRIs as mood stabilisers for Bipolar II Disorder. In: Parker G, ed. Bipolar II Disorder: Modelling, Measuring and Managing. Cambridge, England: Cambridge University Press; 2008.